Titan Pharmaceuticals, Inc. Insurance Commissions
Titan Pharmaceuticals, Inc. reported Insurance Commissions of $108 for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InsuranceCommissions · last filed 2025-08-14
- Titan Pharmaceuticals, Inc. insurance commissions for the quarter ending 2025-06-30 was $108.00, a 12.90% decline year-over-year.
- Titan Pharmaceuticals, Inc. insurance commissions for the quarter ending 2025-03-31 was $110.00K, a 11.29% decline year-over-year.
- Titan Pharmaceuticals, Inc. insurance commissions for the quarter ending 2024-06-30 was $124.00.
- Titan Pharmaceuticals, Inc. insurance commissions for the quarter ending 2024-03-31 was $124.00K.
| Period end | Insurance Commissions 3 month | Insurance Commissions 6 month |
|---|---|---|
| 2025-06-30 | $108.00 10-Q · filed 2025-08-14 | $218.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $110.00K 10-Q · filed 2025-05-14 | |
| 2024-06-30 | $124.00 10-Q · filed 2025-08-14 | $247.00 10-Q · filed 2025-08-14 |
| 2024-03-31 | $124.00K 10-Q · filed 2025-05-14 |